The financial impact on families of children with atopic dermatitis

Archives of Dermatology

Volumn 138, Issue 6, 2002, Pages 819-820

  Emerson, R M ^a   Williams, H C ^a   Allen, B R ^a   Herd, Robert M ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EMOLLIENT AGENT;

ALTERNATIVE MEDICINE; ATOPIC DERMATITIS; CLINICAL RESEARCH; COST OF ILLNESS; EVIDENCE BASED MEDICINE; FAMILY LIFE; HEALTH CARE COST; HUMAN; MEDICAL LITERATURE; NOTE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS; CHILD, PRESCHOOL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; DERMATITIS, ATOPIC; FAMILY; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; MALE; PREVALENCE; QUESTIONNAIRES; STEROIDS;

EID: 0036286138     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (8)

1. The cost of atopic eczema
2. Atopic dermatitis in children: Who cares? Who pays?
3. Atopic eczema: Its impact on the family and financial cost
4. Action asthma
5. The economic burden of asthma in US children: Estimates from the National Medical Expenditure Survey
6. Direct and indirect costs of asthma in Canada, 1990
7. Systematic review of atopic eczema
8. Cost-effectiveness analysis